查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519485

2024-2032 年按產品類型、技術、應用和地區分類的生物技術市場報告

Biotechnology Market Report by Product Type, Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2023年全球生技市場規模達7,149億IMARC Group。個人化醫療的不斷增加的研究和開發（R&D）、基因工程的眾多進步以及對永續農業的需求不斷增加是推動市場的一些主要因素。

生物技術是一個多學科領域，涵蓋利用活有機體、細胞和生物系統來開發創新產品和技術。它涉及在分子和細胞層面上利用生物過程和生物體來應對醫療保健、農業和環境管理等行業的各種挑戰。生物技術包括基因工程、生物製藥、生物資訊學和合成生物學等領域，所有這些領域都旨在創造新的解決方案、改善現有流程並增進我們對生命系統的理解。該領域在塑造現代醫學、永續農業以及開發多種應用的新型材料方面發揮著至關重要的作用。

由於基因研究和分子生物學理解的快速進步，基因編輯、個人化醫療和新療法等領域的不斷創新將刺激預測期內的市場成長。此外，慢性病的盛行率不斷上升以及對標靶治療的需求增加了對生物製藥和精準醫療的需求，從而對市場成長產生積極影響。此外，由於全球人口不斷成長和耕地有限，對永續農業解決方案的需求不斷增加，加速了作物改良和生物農藥領域的生物技術採用。除此之外，生物技術與資訊技術（稱為生物資訊學）的融合增強了研究和開發的數據驅動洞察力，正在推動市場成長。此外，由於對環境永續性的日益關注，生物修復方法和生物燃料的發展也促進了市場的成長。

生物技術市場趨勢/促進因素：

基因工程的快速進展

基因工程領域的顯著進展，以革命性的 CRISPR-Cas9 技術為代表，代表了生物技術市場的主要驅動力。這項技術使科學家能夠精確地修改生物體內的基因，在醫學、農業和工業過程中展現前所未有的應用潛力。在醫療保健領域，基因工程促進了針對遺傳性疾病和癌症的創新基因療法的開發，為個人化治療提供了一個有希望的途徑。此外，改造微生物來生產胰島素和酵素等有價值的化合物的能力已經改變了製藥和工業製造。

對個人化醫療和治療的需求不斷成長

針對個人基因組成量身定做的個人化醫療概念正在生物技術市場上獲得關注。基因組定序技術的進步使得分析個體的遺傳密碼和識別與疾病相關的遺傳變異成為可能。這導致了針對患者獨特遺傳特徵的標靶療法的開發，提高了治療效果並減少了不良反應。生物技術能夠生產單株抗體和基因療法等生物藥品，符合個人化醫療的原則。此外，基於遺傳標記的診斷可以實現早期疾病檢測和預後，從而將醫療保健實踐重塑為更精確和個性化的方法。

對永續農業解決方案的需求不斷成長

全球對糧食的需求不斷成長，加上環境問題和永續農業實踐的需要，推動了農業中生物技術解決方案的採用。旨在提高產量、抗蟲性和營養成分的基因改造作物 (GMO) 是生物技術對農業影響的例子。由於對環境的影響較小，源自自然生物體的生物農藥比傳統化學農藥更受青睞。生物技術提供了最佳化植物性狀、提高作物對氣候變遷的適應能力和提高養分效率的工具，從而有助於糧食安全和資源永續性。這一促進因素反映了生物技術在解決農業部門面臨的緊迫挑戰、同時最大限度地減少生態足跡方面的關鍵作用。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物技術市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 儀器
    • 市場走向
    • 市場預測
  • 試劑
    • 市場走向
    • 市場預測
  • 軟體和服務
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依技術

  • 奈米生物技術
    • 市場走向
    • 市場預測
  • 組織工程與再生
    • 市場走向
    • 市場預測
  • DNA定序
    • 市場走向
    • 市場預測
  • 基於細胞的檢測
    • 市場走向
    • 市場預測
  • 發酵
    • 市場走向
    • 市場預測
  • PCR技術
    • 市場走向
    • 市場預測
  • 色譜法
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 衛生保健
    • 市場走向
    • 市場預測
  • 食品和農業
    • 市場走向
    • 市場預測
  • 自然資源與環境
    • 市場走向
    • 市場預測
  • 工業加工
    • 市場走向
    • 市場預測
  • 生物資訊學
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amgen Inc.
    • Biocon Limited
    • Biogen Inc.
    • F. Hoffmann-La Roche AG
    • Genmab A/S
    • Lonza Group AG
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • Seagen Inc.
    • Syngenta AG
    • Vertex Pharmaceuticals Incorporated
Product Code: SR112024A5785

The global biotechnology market size reached US$ 714.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,277.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.53% during 2024-2032. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.

Biotechnology is a multidisciplinary field that encompasses the use of living organisms, cells, and biological systems to develop innovative products and technologies. It involves harnessing biological processes and organisms at the molecular and cellular level to address various challenges across industries, such as healthcare, agriculture, and environmental management. Biotechnology includes areas like genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all aimed at creating new solutions, improving existing processes, and advancing our understanding of living systems. This field plays a crucial role in shaping modern medicine, sustainable agriculture, and the development of novel materials for diverse applications.

The rising innovation in areas, including gene editing, personalized medicine, and novel therapies, due to rapid advancements in genetic research and the understanding of molecular biology, will stimulate the market growth during the forecast period. Moreover, the increasing prevalence of chronic diseases and the need for targeted treatments have augmented the demand for biopharmaceuticals and precision medicine, thus positively influencing the market growth. Additionally, the heightening demand for sustainable agricultural solutions owing to the expanding global population and limited arable land has accelerated the adoption of biotechnological techniques in crop improvement and biopesticides. Apart from this, the convergence of biotechnology with information technology, known as bioinformatics, that enhances data-driven insights for research and development is propelling the market growth. Furthermore, the development of bioremediation methods and biofuels on account of the escalating focus on environmental sustainability is contributing to market growth.

Biotechnology Market Trends/Drivers:

Rapid advancements in genetic engineering

The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.

Increasing demand for personalized medicine and therapeutics

The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.

Rising need for sustainable agriculture solutions

The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.

Biotechnology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biotechnology market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, technology, and application.

Breakup by Product Type:

Instruments

Reagents

Software and Services

The report has provided a detailed breakup and analysis of the market based on the product type. This includes instruments, reagents, and software and services.

Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.

Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.

Breakup by Technology:

Nanobiotechnology

Tissue Engineering and Regeneration

DNA Sequencing

Cell-Based Assays

Fermentation

PCR Technology

Chromatography

Others

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others.

Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.

Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.

Breakup by Application:

Healthcare

Food and Agriculture

Natural Resources and Environment

Industrial Processing

Bioinformatics

Others

Healthcare dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes healthcare, food and agriculture, natural resources and environment, industrial processing, bioinformatics, and others. According to the report, healthcare represented the largest segment.

Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.

As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.

Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts.

Competitive Landscape:

Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amgen Inc.

Biocon Limited

Biogen Inc.

F. Hoffmann-La Roche AG

Genmab A/S

Lonza Group AG

Novartis AG

Novo Nordisk A/S

Pfizer Inc.

Regeneron Pharmaceuticals Inc.

Seagen Inc.

Syngenta AG

Vertex Pharmaceuticals Incorporated

Recent Developments:

In May 2022, F. Hoffmann-La Roche Ltd, a leading healthcare enterprise headquartered in Switzerland, introduced the innovative breast cancer antibody cocktail drug, PHESGO, to the Indian market. This breakthrough offering comes with a compelling advantage, as it is not only priced at a remarkable 20% lower than existing therapies but also offers a more streamlined and convenient administration process. It specifically targets HER-2 positive breast cancer, a challenging and prevalent subtype, while holding the distinction of being sanctioned for both early and advanced stages, including metastatic cases.

In January 2021, Novartis AG, a renowned pharmaceutical leader, entered into a strategic collaboration with Alnylam, a pioneering biotechnology company specializing in RNA interference (RNAi) technology. This innovative partnership aims to harness Alnylam's cutting-edge small interfering RNA (siRNA) technology to pave the way for a revolutionary targeted therapy. The focus of this collaboration centers on restoring optimal liver function, a critical aspect in numerous medical conditions.

In Jan 2023, Pfizer Inc., a global leader in biopharmaceuticals, collaborated with Gero, an avant-garde biotechnology company renowned for its advanced technology platform. This strategic research collaboration marks a convergence of expertise and technology, aiming to unlock new insights into the complex realm of fibrotic diseases. By harnessing Pfizer's extensive domain knowledge and Gero's state-of-the-art machine-learning capabilities, the partnership endeavors to chart unexplored territories in the understanding of genes and pathways linked to fibrosis - a group of disorders characterized by tissue scarring and dysfunction.

Key Questions Answered in This Report

  • 1. How big is the global biotechnology market?
  • 2. What is the expected growth rate of the global biotechnology market during 2024-2032?
  • 3. What are the key factors driving the global biotechnology market?
  • 4. What has been the impact of COVID-19 on the global biotechnology market?
  • 5. What is the breakup of the global biotechnology market based on the application?
  • 6. What are the key regions in the global biotechnology market?
  • 7. Who are the key players/companies in the global biotechnology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotechnology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Nanobiotechnology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Engineering and Regeneration
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cell-Based Assays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fermentation
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 PCR Technology
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Chromatography
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Food and Agriculture
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Natural Resources and Environment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Industrial Processing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Bioinformatics
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Biocon Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genmab A/S
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novo Nordisk A/S
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Regeneron Pharmaceuticals Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Seagen Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Syngenta AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis
    • 14.3.13 Vertex Pharmaceuticals Incorporated
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biotechnology Market: Major Drivers and Challenges
  • Figure 2: Global: Biotechnology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biotechnology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biotechnology Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Biotechnology Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Biotechnology Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biotechnology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Biotechnology (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Biotechnology (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Biotechnology (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biotechnology (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biotechnology (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biotechnology (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biotechnology (Nanobiotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biotechnology (Nanobiotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biotechnology (Tissue Engineering and Regeneration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biotechnology (Tissue Engineering and Regeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biotechnology (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biotechnology (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biotechnology (Cell-Based Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biotechnology (Cell-Based Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biotechnology (Fermentation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biotechnology (Fermentation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biotechnology (PCR Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biotechnology (PCR Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biotechnology (Chromatography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biotechnology (Chromatography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biotechnology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biotechnology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biotechnology (Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biotechnology (Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biotechnology (Food and Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biotechnology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biotechnology (Natural Resources and Environment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biotechnology (Natural Resources and Environment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biotechnology (Industrial Processing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biotechnology (Industrial Processing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biotechnology (Bioinformatics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biotechnology (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biotechnology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biotechnology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: North America: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: North America: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: United States: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: United States: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Canada: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Canada: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Asia-Pacific: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Asia-Pacific: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: China: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: China: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Japan: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Japan: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: India: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: India: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: South Korea: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: South Korea: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Australia: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Australia: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Indonesia: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Indonesia: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Europe: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Europe: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Germany: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Germany: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: France: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: France: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: United Kingdom: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: United Kingdom: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Italy: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Italy: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Spain: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Spain: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Russia: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Russia: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Latin America: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Latin America: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Brazil: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Brazil: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Mexico: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Mexico: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Middle East and Africa: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Middle East and Africa: Biotechnology Market: Breakup by Country (in %), 2023
  • Figure 90: Middle East and Africa: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Global: Biotechnology Industry: SWOT Analysis
  • Figure 92: Global: Biotechnology Industry: Value Chain Analysis
  • Figure 93: Global: Biotechnology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biotechnology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biotechnology Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biotechnology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Biotechnology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biotechnology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Biotechnology Market: Competitive Structure
  • Table 7: Global: Biotechnology Market: Key Players